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Abstract
Background: Research suggests that the way in which cognitive therapy is delivered is an 
important factor in determining outcomes. We test the hypotheses that the development of a 
shared problem list, use of case formulation, homework tasks and active intervention 
strategies will act as process variables.
Methods: Presence of these components during therapy is taken from therapist notes. The 
direct and indirect effect of the intervention is estimated by an instrumental variable analysis.
Results: A significant decrease in symptom score for case formulation (coefficient=-23, 
95%CI -44 to -1.7, p=0.036) and homework (coefficient=-0.26, 95%CI -0.51 to -0.001, 
p=0.049) is found. Improvement with the inclusion of active change strategies is of 
borderline significance (coefficient= -0.23, 95%CI -0.47 to 0.005, p=0.056). 
Conclusions: There is a greater treatment effect if formulation and homework are involved in 
therapy. However, high correlation between components means that these may be 
indicators of overall treatment fidelity. 
Declarations of interest: None
Introduction
Reliable and valid criteria are now available to identify help-seeking individuals who 
are at increased risk of imminently developing a first episode of schizophrenia or related 
psychoses (FEP). Yung and colleagues  developed operational criteria to identify three 
subgroups experiencing an “at risk mental state” (ARMS) for psychosis. Two subgroups 
specify state risk factors; (1) Brief Limited Intermittent Psychotic Symptoms or (2) attenuated
(subclinical) psychotic symptoms and are defined by the presence of transient psychotic 
symptoms. The other subgroup comprises trait-plus-state risk factors, operationally defined 
by the presence of diminished functioning plus either a first-degree relative with a history of 
psychosis or a pre-existing schizotypal personality disorder. These criteria have now been 
widely adopted, and have led to attempts to deliver interventions that will reduce the risk of 
development of a FEP; effective interventions are attractive because of the significant 
personal, social and financial costs associated with the development of psychosis.  In 
addition, it is clear that people meeting the ARMS criteria have significant mental health 
problems and impaired functioning, regardless of eventual transition. Several randomised 
controlled trials have evaluated the impact of psychosocial and pharmacological 
interventions  on transition to psychosis and the severity of psychotic experiences within this 
population. These studies have found relatively encouraging results, suggesting that such 
interventions can reduce attenuated psychotic symptoms and may delay or prevent 
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psychosis in some instances, and recent meta-analyses have concluded that cognitive 
therapy (CT) significantly reduces the risk of transition to psychosis at 12 months. A 
moderate effect was also reported at 18 months but was not sustained in a sensitivity 
analysis . 
Recent research suggests that the way in which CT is delivered is an important factor
in determining outcomes. For example, in a recent trial of CT for people with psychosis, 
participants derived benefit if they received full therapy that involved active change 
strategies such as evaluation of beliefs and the use of behavioural experiments, whereas CT
was potentially harmful if participants received partial therapy that only involved engagement
and assessment. Within the Early Detection and Intervention Evaluation (EDIE-2)  trial for 
people at risk of psychosis, we found that those allocated to CT received a mean of 9.11 
sessions (s.d.=6.69; range 0 to 26), and acceptability of CT was reasonably good, with only 
9/144 (6.25%) not attending any sessions, and 108/144 (75%) receiving at least 4 or more 
sessions; however, there was clearly considerable variance in number of sessions received. 
In order to examine the contribution of the ‘dose’ of CT, the effects of number of sessions on 
12-month outcomes were estimated through instrumental variable regression using ATR 
(Adjusted Treatment Received) algorithm   (this method is described in detail in the context 
of dose-response effects in psychotherapy trials);  we found a significant effect of sessions 
on severity of psychotic experiences. However, quality of therapy received is likely to be as 
important, if not more so, than quantity alone. CT for people at risk of psychosis is a 
collaborative, problem-orientated approach, which requires the development of a problem list
and shared goal . Our treatment manual  also required that an idiosyncratic case formulation
based on the cognitive model  be developed, and that the use of active change strategies 
such as provision of normalising information, evidential analysis and testing beliefs by 
modification of safety behaviours was present in as many sessions as possible. Similarly, 
our approach required extensive use of between session tasks to facilitate change (i.e. 
homework tasks). 
A recent Delphi study of expert opinion regarding the essential components of CT for 
psychosis produced consensus regarding the importance of such factors. However, to date, 
the assumption that such components of CT are associated with outcome is an untested 
hypothesis. Our study, which is a secondary analysis of the EDIE-2 trial, aims to test the 
specific hypotheses that the development of a shared problem list, use of a case formulation 
based on the cognitive model, use of homework tasks between sessions and use of active 
intervention strategies outlined in the manual will act as process variables, increasing the 
effect of CT if received.
Methods
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Trial design
EDIE-2, is a multi-centre randomised controlled trial of psychotherapy for the 
prevention of psychosis in those at high risk. The trial compared cognitive behavioural 
therapy with mental state monitoring (CBT) versus mental state monitoring alone (TAU). 288
help-seeking participants aged between 14-35 years who did not have a diagnosis of 
psychosis but satisfied the Comprehensive Assessment for At-Risk Mental State (CAARMS) 
criteria for at-risk mental state, were randomised to CBT or TAU within each of the 5 sites; 
Manchester, Birmingham/Worcester, Glasgow, Cambridge and Norfolk. Exclusion criteria 
were previous or current anti-psychotic medication for more than two days, moderate to 
severe learning difficulties and insufficient English. 
Demographic and clinical characteristics of the participants were collected prior to 
randomisation. Clinical outcomes were collected at monthly intervals for the first 6 months 
and then every 3 months to a maximum of 24 months or until the end of the trial. The 
primary outcome is recorded 12 months after randomisation.
Assessment of putative treatment mechanisms
Therapist notes of CT sessions carried out as part of the EDIE-2 trial were evaluated 
for evidence of particular aspects of therapy that should be present. They can broadly be 
grouped into four components in line with a recent Delphi study : having a shared problem 
list, development of a case formulation based on the cognitive model, use of homework 
tasks between sessions and use of active change strategies specified in the manual within 
sessions. The classifications are dependent upon detailed and accurate notes and so 
provide a conservative estimate of the occurrence of the practices i.e. if there was not clear 
evidence in the therapy process notes that a particular aspect of therapy was conducted 
then it was not recorded as present.
Assessment of problems and goals
Problem assessment is considered present if in any session there was a formal list of
the participant’s problems and goals. This is a binary measure as it is not necessarily 
expected to occur more than once during the course of therapy.
Formulation
Formulation is a detailed account of the patient’s difficulties, based on the specific 
cognitive model of psychosis that was utilised within the trial. It is recorded as present if 
there was clear evidence within the notes (i.e. a copy of the formulation was included). As 
with problem assessment, it is a binary measure since the requirement to demonstrate 
fidelity within therapy was to have at least one formulation evident in the notes. However, it 
is likely that many participants will have had multiple formulations.
Homework 
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Homework was recorded as present at each session if a review of the previous 
homework task was recorded in the notes. Additional detail on the type of homework given 
was also recorded under the groupings of behavioural experiment (changing reactive 
behaviours), monitoring and education. The proportion of sessions in which homework was 
involved was calculated as a continuous measure and also dichotomised at 50% of sessions
to be analysed as a binary measure.
Active change strategies
The involvement of active change strategies was recorded for each session if any of 
the following intervention strategies were evident in the notes: provision of normalising 
information, generating alternative explanations for problematic appraisals, manipulation of 
safety behaviours, evaluation of metacognitive beliefs or responses, evaluation of beliefs 
about self and others, efforts to reduce social isolation and attempts to promote relapse 
prevention. As with homework, the proportion of sessions involving any one of these other 
interventions as well as a dichotomised version (using 50%) of this variable was created.
Additionally we created a binary variable indicating participants who received all of 
these components of therapy versus some or none of them and a three-category variable 
indicating all, some and none. For all of these process variables, the processes were coded 
as being absent (i.e. equal to 0) for the participants in the control (TAU) group.
Outcome
We use the CAARMS to measure symptom severity, this a semi-structured interview 
to discuss recent experiences followed by a clinician rated scale of symptoms, frequency 
and distress under the following subheadings: disorders of thought content, perceptual 
abnormalities, conceptual disorganisation, motor changes, concentration and attention, 
emotion and affect, subjectively impaired energy and impaired tolerance to normal stress. 
This measure accounts separately for the frequency and severity of symptoms and 
combines to form a product of the two so can be sensitive to small changes in experiences. 
Yung et al showed the measure to have good inter-rater reliability with an ICC of at least 
0.62 on each subscale and an overall ICC of 0.85. In this study we use a shortened version 
consisting of only the unusual thought content, non-bizarre ideas, perceptual abnormalities 
and disorganised speech subscales. Inter-rater reliability of the CAARMS was assessed on 
eight occasions over the course of the EDIE-2 trial and reported in the baseline paper, the 
mean intra-class correlation was 0.90 (sd=0.03). 
Covariates
Socio-demographic (age, sex, education, occupation) and health measures (anxiety: 
Social Interactions and Anxiety Scale (SIAS), depression: Beck’s Depression Inventory 
(BDI), functioning: Global Assessment of Functioning (GAF) and quality of life: EQ5D and 
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Manchester Short Assessment of Quality of Life (MANSA)) as well as the CAARMS severity 
and distress from symptoms were recorded prior to randomisation.  
Statistical Analysis
A descriptive account of the associations between baseline characteristics and 
content of therapy received in the intervention arm only are described using chi-squared and
t-tests.
To determine the effect of receiving a specific aspect of therapy it is assumed that 
there is an effect of being randomised to therapy even if this specific part of therapy is not 
given (through other mechanisms) and an additional effect of receiving the specific aspect of
therapy in question. This can be considered similar to a mediation analysis. Since the 
content of therapy is not randomised there will be confounding present: there will be factors 
that influence whether a patient has a problem assessment/formulation/homework/active 
change strategy that will also influence their treatment outcome, for example, age or 
education. In order to remove confounding from factors that have not or cannot be measured
we apply an instrumental variable analysis using two-stage least squares estimation. 
The causal effect of each aspect of therapy on outcome at 12 month follow-up is 
investigated individually. Baseline covariates by randomisation group interactions are 
considered as instruments. To select the most effective instruments the backward stepwise 
model selection method is used since no instrument has been set prior to the analysis. The 
selection is carried out to determine baseline variables associated with the process within 
the CBT arm only and these are used as instruments when interacted with randomisation 
group. The analyses allow for a direct effect of randomisation to CBT even if the particular 
aspect of therapy in question was not received. All analyses are adjusted for the baseline 
measure of symptom severity and bootstrapped with 1000 replications.
The data were initially analysed using complete cases only and results reported. 
Missing covariates are judged to be likely to be missing at random, meaning that the 
probability of missing data can be modelled by the observed data. To improve efficiency, 
missing covariate values are imputed using chained equations with the ‘ice’ command in 
Stata . This is carried out on the full dataset, including all variables used in this analysis as 
well as follow-up data from all time points and variables thought to be related to non-
response. Five imputations were created using all variables. Variables were imputed using 
the appropriate model: linear, logistic or multinomial logistic. The matching method was used
for variables with skewed distributions to maintain the shape and range of the distributions. 
The matching method predicts the missing value and then allocates the closest non-missing 
prediction as the imputed value. Missing values of the outcome variables are imputed 
together with the covariates; however, analyses only use imputed information for baseline 
covariates and do not include respondents without an outcome reported. Analyses are run 
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on the imputed datasets separately and pooled using Rubin’s rules in excel to give estimates
and their variances.
Results
The EDIE-2 trial recruited 288 participants at high risk of psychosis who were 
randomised to mental state monitoring only (TAU=144) or CBT plus mental state monitoring 
(CBT=144). The average age of participants was 21 years (sd=4.2), they were 
predominantly white (n=252, 90%) and male (n=180, 63%), full characteristics by treatment 
allocation are described in detail in the preliminary EDIE-2 trial paper.
Heterogeneity was present in the treatment actually received by participants in the 
CBT arm. Our conservative analysis of the therapy notes indicated that the following 
numbers of participants clearly received these elements of therapy: 100 (69%) had an 
assessment of problems and goals, 79 (55%) had received formulation at some point in their
therapy. On average 39% (sd=32) of sessions involved homework and 43% (sd=34) 
involved other interventions. The notes clearly indicated that 36 (25%) participants received 
all four components of therapy, while the notes did not record any element for 28 (19%). 
Individual associations between the characteristics of patients within the intervention arm 
and the treatment received are detailed in Table 1 and Table 2, the tables show observed 
values with significant associations indicated for observed and imputed data. Greater anxiety
(SIAS) was associated with receiving each aspect of therapy. Treatment centre was 
associated with receiving a problem assessment, formulation and other interventions but not 
homework. Lower functioning (GAF) was associated with having a problem assessment and 
other interventions. Receiving a problem assessment was also more likely in female 
participants. The components of intervention are correlated with each other and with the 
number of therapy sessions attended; the associations are detailed in Table 3.
The primary analysis of the EDIE data indicated a significant improvement in severity
of symptoms for those randomised to receive CBT (coefficient=-5.12, 95% CI -8.60 to -1.64, 
p=0.004). When each aspect of therapy is considered separately as a mechanism of CBT 
there is no longer a significant direct effect of randomisation on severity of symptoms (Table 
4). The results are very similar between the complete case analysis and the imputed 
datasets. The instrumental variables analysis indicates that there is no significant additional 
treatment effect through problem assessment (imputed coefficient=-10.9 (-29 to 7.4), 
p=0.243). There is a significant additional decrease in symptom score estimated for case 
formulation (estimated 23 point decrease, 95% CI -44 to -1.7, p=0.036) and the proportion of
sessions involving homework (estimated 0.26 point decrease 95% CI -0.51 to -0.001, 
p=0.049). The results suggest that including active change strategies in therapy improves 
outcomes though the estimate is of borderline significance when assessed at the 5% level 
(estimated 0.23 point decrease, 95% CI -0.47 to 0.005, p=0.056).
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Receiving all aspects of therapy is expected to reduce symptom severity by 20 points
(95% CI -40 to 0.22, p=0.053) compared to those who receive only some or none of the 
components, this is again of borderline significance. When it is assumed that participants 
who do not receive any of the four components of therapy have no treatment effect there is 
no significant improvement in symptoms from receiving some aspects of therapy but a 
significant improvement is seen when all four components are applied.
Discussion
Summary of findings
This analysis of components of therapy as possible mechanisms of change within CT
for people at risk of developing FEP accounts for potential unmeasured confounding 
between the mechanism and outcome, which is an important advance on previous research.
We found that there was a greater effect of treatment if formulation and homework are 
involved in therapy and a suggestion that active change strategies also improve symptoms, 
which confirms the consensus of therapist opinion and the approach recommended in our 
treatment manual. When examining the effects on outcomes, there was no direct effect of 
randomisation, suggesting that allocation to therapy per se is not sufficient to produce 
change; rather, it is the quality of the therapy provided that results in change in clinical 
outcomes. 
The importance of a case formulation in CT for psychosis has been discussed, but 
previous studies have failed to show a relationship between formulation and treatment 
outcomes in people with psychosis ; this is the first study to demonstrate empirically an 
effect of formulation on outcome in CT for people at risk of psychosis. Similarly, attempts to 
demonstrate the effects of homework tasks on outcome have previously been unsuccessful ;
it is likely that this is due to the limited statistical power resulting from small sample sizes in 
the studies to date. The effects of active change strategies have been shown to be related to
clinical response to CT in people with psychosis ; we have replicated this finding in people at
risk of psychosis. The lack of an effect of having a problem list is interesting; it may be that 
this is a necessary, but not sufficient, condition for achievement of clinical improvement. 
Given that CT is a collaborative and problem-orientated approach, it is likely to be very 
difficult to develop a formulation, collaboratively set homework tasks and utilise active 
change strategies in the absence of a shared list of problems and goals. The high correlation
between the components of therapy and with the number of therapy sessions attended 
means that we cannot attribute the treatment effect seen for one component apart from 
another. This is reflected in the similar magnitudes of estimated treatment effects and it is 
likely that they are all indicating the general effect of fidelity to treatment. The strong effect of
having any versus none of these is consistent with such a suggestion. 
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Methodological limitations and recommendations for future research
The presence of treatment components was determined by inspection of the therapy 
process notes, and assumed to be not present if not explicitly evident; this may have lead to 
components of therapy being under-reported (which at least provides a conservative test of 
the hypotheses), and may be confounded by therapists administrative abilities. Also, we did 
not specify at the start of the trial that the process notes would be utilised for this purpose; 
this may have resulted in greater variability in the recording of such information than if it had 
been explicitly stated from the outset but would additionally not be influenced by the 
knowledge that the data are being monitored. Females were found to be more likely to 
receive an assessment of problems and goals. Given that no gender difference is found for 
the other components, it may be a chance finding due to multiple testing when looking at 
individual associations, but it is also possible that the ability to engage in a therapeutic 
relationship and develop collaborative goals may be greater in females, which could help to 
explain the widely accepted finding that women with psychosis have better outcomes than 
men. Trial site, however, was individually associated with each component of therapy apart 
from homework. Though regular homework use is not statistically associated with trial site 
the pattern of use among the sites is similar to the other components. Differences may be 
due to variations in application of the therapy, characteristics of patients or completion of 
notes but highlights the importance of consistency in application of the therapeutic model.
In order to test the hypotheses, we would ideally have randomised participants to 
receive specific aspects of therapy, but this approach is not feasible within a definitive trial of
a complex intervention such as CT; however, the instrumental variable approach tries to 
account for the problems of confounding associated with not being randomised. While this 
approach to mediation analysis represents a significant advance over traditional methods 
that do not account for unmeasured confounding, there are several issues that need to be 
considered. Two assumptions are made about the instruments, the first is that they are 
associated with the component of therapy in question and the second is that they only 
influence severity of symptoms at follow-up through their effects on receipt of the therapy 
component. The instruments used are interactions of baseline covariates with randomisation
arm. The first assumption is therefore valid since the covariates selected for the interactions 
are specifically chosen as the variables most associated with receipt of the component of 
therapy in the CBT arm of the trial. The second assumption cannot be tested; we assume 
that the benefits of randomisation hold and there is no reason to expect a difference in the 
association between covariates and outcome in the two treatment arms other than through 
the baseline characteristics affecting the components of therapy received. However, since 
the variables associated with one component may be associated with others the instruments
could affect the outcome through these other pathways invalidating the assumption. If it is 
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the case that the components are in fact measuring a more general fidelity to treatment this 
may not be a concern. 
The confidence intervals for the estimates are very wide, indicating a degree of 
uncertainty in the magnitude of the effects. Instruments must be selected that explain a large
proportion of the heterogeneity in the treatment received. To ensure that the most effective 
instruments are selected we have used the data reduction technique, backward stepwise 
selection. There may be some impact on the results over the choice of instrument, however 
a sensitivity analysis using all covariate by randomisation arm interactions and selection 
using a shrinkage approach, the LASSO (Least Absolute Shrinkage and Selection Operator) 
produce similar results giving confidence in our analysis. 
Implications
There are several clinical implications of this study. It is important to emphasise the 
development of a case formulation, the use of homework tasks between sessions and the 
incorporation of active change strategies within sessions in both training of therapists and 
delivery of therapy. Early development of a shared formulation would be desirable e.g. an 
analysis of a recent incident in terms of events, appraisal of events, associated physical and 
emotional feelings and the cognitive and behavioural responses. It is likely that a more 
comprehensive formulation that incorporates information regarding life experience and 
beliefs will occur later in the therapy process. The use of homework tasks is clearly important
in determining outcome; thus, ensuring that previous tasks are reviewed and new tasks set 
will be important. It is likely that collaborative development of such tasks, allocation of 
sufficient time to developing such tasks and planning for obstacles to implementation are 
likely to promote successful completion; however, such hypotheses could be tested in future 
research. The use of active change strategies is likely to be facilitated by use of therapist 
reminders or prompts and routine monitoring of the implementation of such intervention 
strategies. Sharing the findings of this research with service users is also likely to be 
beneficial; thus, ensuring service users are aware that a shared formulation, conducting 
tasks between sessions and an active stance within sessions are all associated with good 
clinical outcomes is likely to facilitate the implementation of such components.   
In conclusion, we have found that there is a greater treatment effect if formulation 
and homework are involved in therapy; however, given the high correlations between such 
components, it is possible that these may be indicators of overall treatment fidelity and it 
may be that the other aspects of adherence to the therapy protocol may also be important. 
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Table 1: Demographic associations with content of therapy received - CBT arm only
Assessment of problems
and goals Formulation Homework Active change strategies
No Yes
p-
value No Yes
p-
value No Yes
p-
value No Yes
p-
value
Gender Male: n (%)
33
(37%)
56
(63%)  
41
(46%)
48
(54%)  
48
(54%)
41
(46%)  
45
(51%) 44 (49%)
 Female: n (%)
11
(20%)
44
(80%) 0.03
24
(44%)
31
(56%) 0.78
33
(60%)
22
(40%) 0.48
27
(49%) 28 (51%) 0.86
Age  mean (sd) 20 (3.9) 21 (4.3) 0.28 20 (4.1) 21 (4.3) 0.46 20 (3.7) 21 (4.7) 0.08 20 (3.9) 21 (4.4) 0.06
Ethnicity Non-white: n (%) 3 (21%)
11
(79%) 4 (29%)
10
(71%) 8 (57%) 6 (43%) 7 (50%) 7 (50%)
 White: n (%)
40
(31%)
88
(69%) 0.45
61
(48%)
67
(52%) 0.17
72
(56%)
56
(44%) 0.95
65
(51%) 63 (49%) 0.96
Site Manchester: n (%) 4 (10%)
36
(90%)
12
(30%)
28
(70%)
17
(43%)
23
(58%)
16
(40%) 24 (60%)
 Birmingham: n (%)
14
(36%)
25
(64%)
14
(36%)
25
(64%)
26
(67%)
13
(33%)
21
(54%) 18 (46%)
 Cambridge: n (%) 3 (21%)
11
(79%) 5 (36%) 9 (64%) 6 (43%) 8 (57%) 3 (21%) 11 (79%)
 Norfolk: n (%)
16
(76%) 5 (24%)
18
(86%) 3 (14%)
13
(62%) 8 (38%)
16
(76%) 5 (24%)
 Glasgow: n (%) 7 (23%)
23
(77%) <0.01
16
(53%)
14
(47%) <0.01
19
(63%)
11
(37%) 0.15
16
(53%) 14 (47%) 0.02
Years of 
education mean (sd)
12.8
(2.1)
13.3
(2.3) 0.27
12.9
(2.3)
13.4
(2.2) 0.16
12.9
(2.0)
13.5
(2.5) 0.08 12.9 (2.1)
13.4
(2.3) 0.12
Continuing 
Education
 
No: n (%)
16
(43%)
21
(57%)
21
(57%)
16
(43%)
22
(59%)
15
(41%)
22
(59%) 15 (41%)
Yes: n (%)
22
(26%)
62
(74%) 0.06
35
(42%)
49
(58%) 0.13
42
(50%)
42
(50%) 0.34
35
(42%) 49 (58%) 0.07
Degree No: n (%)
33
(32%)
71
(68%)
49
(47%)
55
(53%)
55
(54%)
49
(46%)
49
(47%) 55 (53%)
 Yes: n (%) 5 (26%)
14
(74%) 0.64 8 (42%)
11
(58%) 0.69
11
(54%) 8 (46%) 0.69 9 (47%) 10 (53%) 0.98
Occupation Seeking work/other: n (%)
12
(26%)
34
(74%)
21
(46%)
25
(54%)
25
(53%)
21
(47%)
21
(46%) 25 (54%)
 
Employed/Student/Home: n 
(%)
27
(34%)
52
(66%) 0.35
37
(47%)
42
(53%) 0.90
43
(58%)
36
(42%) 0.99
39
(49%) 40 (51%) 0.69
Table 2: Associations between baseline health measures and each content of therapy received - CBT arm only
Assessment of Problems and Goals Formulation Homework Active Change Strategies
p-value p-value p-value p-value
No Yes
Complet
e Case
Impute
d No Yes
Complet
e Case
Impute
d No Yes
Complete
Case
Impute
d No Yes
Complet
e Case
Impute
d
SIAS: 
mean 
(sd)
37.2 
(15.3)
45.6 
(17.1) <0.01 0.04
38.7 
(16.4)
46.7 
(16.6) <0.01 0.04
38.5 
(17.0)
48.1 
(15.4) <0.01 <0.01
36.3 
(16.1)
49.4 
(15.2) <0.01 <0.01
BDI: 
mean 
(sd)
9.6  
(3.7)
10.8 
(4.3) 0.12 0.26
10.3 
(3.8)
10.5 
(4.4) 0.82 0.77
10.5 
(4.3)
10.4 
(4.0) 0.89 0.75
10.4 
(4.3)
10.4 
(4.0) 0.93 089
Severity: 
mean 
(sd)
37.0 
(16.2)
39.5 
(17.1) 0.43 0.38
36.4 
(16.8)
40.7 
(16.8) 0.13 0.11
39.1 
(17.4)
38.8 
(16.2) 0.79 0.70
37.1 
(18.3)
40.4 
(15.1) 0.24  0.12
Distress: 
mean 
(sd)
42.2 
(20.9)
43.0 
(20.5) 0.82 0.63
40.8 
(20.2)
44.3 
(20.8) 0.34 0.29
41.0 
(20.5)
44.9 
(20.5) 0.28 0.49
41.2 
(22.3)
44.2 
(18.8) 0.41 0.19
GAF: 
mean 
(sd)
54.2 
(10.9)
49.6 
(10.8) 0.02 0.02
52.5 
(11.5)
49.7 
(10.4) 0.13 0.13
52.4 
(11.0)
49.2 
(10.7) 0.98 0.08
52.8 
(12.2)
49.1 
(9.3) 0.04  0.05
EQ5: 
mean 
(sd)
0.65 
(0.25)
0.56 
(0.29) 0.08 0.07
0.62 
(0.28)
0.56 
(0.29) 0.28 0.23
0.58 
(0.29)
0.60 
(0.28) 0.71 0.45
0.61 
(0.29)
0.56 
(0.28) 0.35 0.52
MANSA: 
mean 
(sd)
4.01 
(0.75)
3.77 
(0.79) 0.11 0.12
3.86 
(0.80)
3.83 
(0.77) 0.88 0.88
3.94 
(0.82)
3.73 
(0.72) 0.14 0.14
3.90 
(0.79)
3.79 
(0.78) 0.46 0.46
SIAS: Social Interactions and Anxiety, BDI: Beck’s Depression Inventory , GAF: Global Assessment of Functioning, EQ5D: European Quality of
Life, MANSA: Manchester Short Assessment of Quality of Life 

Table 3: Associations between components of therapy
Sessions
attended Problem agreement Formulation >50% homework
mean (sd) No Yes No Yes No Yes
Problem Agreement No 4.5 (5.2)       
 Yes 10.9 (6.3)       
Formulation No 4.8 (4.9) 37 (84%) 28 (28%)     
 Yes 12.4 (6.0) 7 (16%) 72 (72%)     
>50% sessions with homework No 7.1 (6.4) 34 (77%) 47 (47%) 47 (72%) 34 (43%)   
 Yes 11.3 (6.7) 10 (23%) 53 (53%) 18 (28%) 45 (57%)   
>50% sessions with active 
change strategy 
No 5.6 (5.0) 35 (80%) 37 (37%) 51 (78%) 21 (27%) 58 (72%) 14 (22%)
Yes 12.3 (6.5) 9 (20%) 63 (63%) 24 (22%) 58 (73%) 23 (28%) 49 (78%)
Note: all associations are significant at the 5% level
Table 4: Instrumental variables analysis of each potential mechanism of CBT on severity of symptoms at 12 months follow-up 
Effect
Complete Case Imputed
Coefficient Std.Error Normal 95% CI Coefficient SE Estimate p
Agreement of problems and goals
Randomisation -0.24 7.64 -12.48 17.47 -0.38 6.73
0.95
5
Agreement of problems and goals -6.15 9.83 -28.18 10.33 -10.94 9.37
0.24
3
Case formulation
Randomisation -3.97 6.28 -14.95 9.68 4.49 6.49
0.49
0
Formulation -1.73 9.16 -21.20 14.70 -22.99 10.85
0.03
6
% of sessions involving homework
Randomisation 11.064 10.109 -5.908
20.41
7 1.952 5.701
0.73
2
% sessions with homework* -0.361 0.209 -0.542
-
0.032 -0.258 0.131
0.04
9
>50% of sessions involving homework
Randomisation -1.21 5.04 -10.44 9.32 -0.58 5.44
0.91
5
>50% sessions with homework -8.46 7.75 -25.27 5.13 -17.44 10.27
0.09
3
% of sessions involving active change strategies
Randomisation 1.779 7.475 -7.493
21.80
7 2.174 5.815
0.70
9
% sessions with active change 
strategies* -0.135 0.139 -0.504 0.043 -0.233 0.121
0.05
6
>50% of sessions involving active change strategies
Randomisation 0.48 5.98 -6.01 17.43 1.73 5.64
0.76
0
>50% sessions with active change -9.44 8.93 -34.62 0.36 -18.52 10.21 0.07
strategies 6
2-category fidelity measure
Randomisation 10.69 11.95 -3.58 43.27 -3.18 3.58
0.37
4
All components -18.21 13.85 -55.33 -1.02 -20.13 10.38
0.05
3
3-categority fidelity measure
Some components -3.75 4.00 -10.81 4.88 -4.31 5.29
0.41
6
All components -6.60 8.40 -26.47 6.47 -22.81 8.55
0.00
8
  *Change in treatment effect for each 1% increase in the process measure. 
